Coherus Oncology enters ATM equity sales agreement for up to $50 million common stock offering

Reuters2026/08/28 21:12

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Coherus Oncology entered an at-the-market sales agreement with Leerink Partners to sell up to USD 50 million of common stock.
Sales may occur from time to time through the agent, acting as agent or principal, under Rule 415.
Leerink is eligible for commissions of up to 3% of gross proceeds; either party can terminate with 10 days’ notice.
Shares will be offered under the company’s existing Form S-3 shelf registration statement, with a prospectus supplement dated Aug. 28, 2026.
Net proceeds are earmarked for general corporate purposes, including working capital.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coherus Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-103316), on August 28, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Coherus Oncology enters ATM equity sales agreement for up to $50 million common stock offering

You may also like

Crypto prices